A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
Clinical trial NCT04002297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04002297
- Sponsor
- BeOne Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2027-03-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.